XML 38 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2018
Dec. 31, 2017
Equity [Abstract]    
Schedule of assumptions used in Black-Scholes pricing model to estimate the fair value of the options granted
   Six Months
Ended
 
   June 30, 
   2018 
Expected volatility   159.0-167.0% 
Expected life of option   5.2-6.3 
Risk free interest rate   2.3-2.8% 
Expected dividend yield   0.0%

    December 31,  
    2017     2016  
Expected volatility     116.1-159.0 %     76.6-139.2 %
Expected life of option     5.0-7.0       5.5  
Risk free interest rate     1.7-2.2 %     1.1%-1.8 %
Expected dividend yield     0.0 %     0.0 %

Schedule of stock option activity
          Weighted  
    Number of     Average
Exercise
 
    Options     Price  
Stock Options:            
Outstanding at January 1, 2018     980,588     $ 5.02  
Granted     85,830       6.11  
Expired or canceled, during the period     -       -  
Forfeited, during the period     (2,909 )     3.65  
Outstanding at June 30, 2018     1,063,509     $ 5.13  
Exercisable at June 30, 2018     554,196     $ 6.59  
   Number of
Options
   Weighted
Average
Exercise
Price
 
Outstanding at January 1, 2017   573,110   $6.94 
Granted   611,522    3.75 
Expired or canceled, during the period   (191,027)   6.64 
Forfeited, during the period   (13,017)   6.00 
Outstanding at December 31, 2017   980,588   $5.02 
Exercisable at December 31, 2017   448,890   $8.36
Schedule of stock-based compensation expense

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2018   2017   2018   2017 
Cost of revenue  $651   $1,124   $1,341   $2,240 
Sales and marketing expense   971    307    2,221    575 
Product development expense   12,873    29,151    19,260    33,231 
General and administrative expense   203,518    168,629    399,030    287,493 
Total stock compensation expense  $218,013   $199,211   $421,852   $323,539 

 

   Year ended
December 31,
 
   2017   2016 
Cost of revenue  $4,302   $117,147 
Sales and marketing expense   1,784    - 
Product development expense   166,783    - 
General and administrative expense   665,556    50,599 
Total stock-based compensation expense  $838,425   $167,746 
Schedule of restricted stock award activity

          Weighted  
          Average  
    Number of     Grant Date  
    RSAs     Fair Value  
Restricted Stock Awards:            
Outstanding at January 1, 2018   $ 158,571     $ 20.29  
Granted     -       -  
Expired or canceled, during the period     -       -  
Forfeited, during the period     -       -  
Outstanding at June 30, 2018   $ 158,571     $ 20.29  

   Number of
Restricted
Stock
Awards
   Weighted
Average
Grant Date
Fair Value
 
Outstanding at January 1, 2017   264,286   $20.29 
Granted   -    - 
Forfeited or canceled, during the period   (43,405)   20.29 
Vested   (62,310)   20.29 
Outstanding at December 31, 2017   158,571   $20.29